Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer.
Kaźmierczak D, Eide IJZ, Gencheva R, Lai Y, Lewensohn R, Tsakonas G, Grundberg O, de Petris L, McGowan M, Brustugun OT, Ekman S, Hydbring P. Kaźmierczak D, et al. Among authors: brustugun ot. Transl Lung Cancer Res. 2022 May;11(5):722-734. doi: 10.21037/tlcr-21-955. Transl Lung Cancer Res. 2022. PMID: 35693293 Free PMC article.
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM. Rud AK, et al. Among authors: brustugun ot. BMC Cancer. 2013 Nov 11;13:540. doi: 10.1186/1471-2407-13-540. BMC Cancer. 2013. PMID: 24215488 Free PMC article.
BRAF-mutations in non-small cell lung cancer.
Brustugun OT, Khattak AM, Trømborg AK, Beigi M, Beiske K, Lund-Iversen M, Helland Å. Brustugun OT, et al. Lung Cancer. 2014 Apr;84(1):36-8. doi: 10.1016/j.lungcan.2014.01.023. Epub 2014 Feb 3. Lung Cancer. 2014. PMID: 24552757
Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas.
Bjaanaes MM, Halvorsen AR, Solberg S, Jørgensen L, Dragani TA, Galvan A, Colombo F, Anderlini M, Pastorino U, Kure E, Børresen-Dale AL, Brustugun OT, Helland A. Bjaanaes MM, et al. Among authors: brustugun ot. Int J Cancer. 2014 Oct 15;135(8):1812-21. doi: 10.1002/ijc.28828. Epub 2014 Mar 14. Int J Cancer. 2014. PMID: 24599520 Free PMC article.
PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.
McGowan M, Hoven AS, Lund-Iversen M, Solberg S, Helland Å, Hirsch FR, Brustugun OT. McGowan M, et al. Among authors: brustugun ot. Lung Cancer. 2017 Jan;103:52-57. doi: 10.1016/j.lungcan.2016.11.018. Epub 2016 Nov 28. Lung Cancer. 2017. PMID: 28024696
High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.
Helland Å, Brustugun OT, Nakken S, Halvorsen AR, Dønnem T, Bremnes R, Busund LT, Sun J, Lorenz S, Solberg SK, Jørgensen LH, Vodak D, Myklebost O, Hovig E, Meza-Zepeda LA. Helland Å, et al. Among authors: brustugun ot. Int J Cancer. 2017 Jul 1;141(1):184-190. doi: 10.1002/ijc.30726. Epub 2017 Apr 21. Int J Cancer. 2017. PMID: 28387924 Free PMC article.
145 results